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2.3,95% C.I. 1.0-5.3). HTLV-1 seropositivity was
also associated with frequency of needle sharing
(Table 1).
Re-use of contaminated needles and other para-
phernalia to prepare the dose were not associated
with HTLV-I seropositivity. Anti-HTLV-I anti-
bodies were detected more commonly among fe-
males (25%) than males (15%), but the difference
was not significant (Odds Ratio=2.9, 95% C.I.
0.9-4.0). Having sex with more than 10 partners in
one year was reported by 24% IDUs (42% seroposi-
tive and 19% seronegative IDUs), resulting associ-
ated with HTLV-I (OR=3.7, 95% C.I. 1.7-8.2). A
large number of sexual partners was the only risk
behaviour in 9 subjects who did not admit to needle
sharing in the last 5 years. This pattern of sexual
behaviour was not associated with needle sharing,
acting as an independent risk factor.
The mode of transmission of HTLV-I infection
among IDUs seems to be similar to that of HIV.
HIV seropositive IDUs are more likely to have anti-
HTLV-I antibodies than seronegative subjects.^
Even if needle sharing seems to be the most
important way of transmission of HTLV-I infection
among IDUs, sexual behaviour might play a role in
HTLV-I spread and account for some cases of
transmission. However, in the cases presumably
acquired through sexual intercourse, transmission
via contaminated 'works' in the early 1980s could
not be ruled out. In fact, HTLV-I antibodies have
been detected in sera collected in IDUs in Rome at
least since 1985.'
Risk reduction measures such as use of sterile
equipment and safe sex, recommended for hepatitis
B virus and HIV infection, should reduce also the
spread of HTLV-I infection.
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Effects of cigarette advertising: reply to
Boddewyn
From Kenneth Warner (Institute of Gerontology,
University of Michigan)
SIR—In his recent commentary on the effects of
cigarette advertising J. J. Boddewyn', who describes
himself as a "paid expert witness for the tobacco
industry", makes a highly misleading and distorting
assessment of the evidence.
His commentary, which criticizes an article by
Chetwynd et al.^ offers selective assertions many of
which fail to approach the exacting standards of
scientific rigor he criticizes Chetwynd for not
attaining. For example, he claims that there is
"strong international evidence that [cigarette adver-
tising] bans are not effective in achieving their
stated purpose, namely, to reduce smoking initiation
and prevalence". As his source Boddewyn cites his
own work', a document paid for and produced by
the Intemational Advertising Association, an organ-
ization with an obvious interest in the outcome of
the debate. As a scholar who has reviewed the
evidence on this issue'' I find this booklet uncon-
vincing and characterized by weak method-
ology.
Boddewyn concludes his commentary by sug-
gesting that the Surgeon General of the United
States agrees with his view that the attempt to link
advertising to smoking is 'difficult' if not 'futile', as
is "attempting to prove that bans are effective in
reducing consumption". This assertion is supported
by quoting one sentence, and a portion of a second,
from the 1989 US Surgeon General's report'
completely out of context. The tobacco and adver-
tising industries have misquoted these sentences on
numberous occasions, creating an entirely false
impression of what the Surgeon General actually
said. The Surgeon General himself, Everett Koop,
became so annoyed by this repeated distortion that
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he published a rebuttal of it^. The effect of this
distortion can be seen when the two sentences are
presented in context in which they actuall appear.
The material omitted by Boddewyn is in italics.
"There is no scientifically rigorous study avail-
able to the public that provides a definitive
answer to the basic question of whether advertis-
ing and promotion increase the level of tobacco
consumption. Given the complexity of the issue,
none is likely to be forthcoming in the forseeable
future. The most comprehensive review of both the
direct and indirect mechanisms concluded that the
collective empirical, experiential, and logical evi-
dence makes it more likely than not that advertis-
ing and promotional activities do stimulate cigar-
ette consumption. However, that analysis also
concluded that the extent of influence of adver-
tising and promotion on the level of consump-
tion is unknown and possibly unknowable (pp.
516-517).
That Boddewyn should find the evidence relat-
ing cigarette advertising to consumption uncon-
vincing is perhaps not surprising. The tobacco
industry, for whom he is a consultant, remains
unconvinced that smoking causes disease. Perhaps
he should have read the Surgeon General's reports
more thoroughly than he apparently did, containing
as it does a thorough review of evidence on the
ways advertising and promotion may increase both
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